130 related articles for article (PubMed ID: 5954449)
1. Side effects of some antimotion sickness drugs as measured by psychomotor test and questionnaires.
Kennedy RE; Wood CD; Graybiel A; McDonough RB
Aerosp Med; 1966 Apr; 37(4):408-11. PubMed ID: 5954449
[No Abstract] [Full Text] [Related]
2. Evaluation of antimotion sickness drug side effects on performance.
Wood CD; Manno JE; Manno BR; Redetzki HM; Wood MJ; Mims ME
Aviat Space Environ Med; 1985 Apr; 56(4):310-6. PubMed ID: 3888169
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of sixteen anti-motion sickness drugs under controlled laboratory conditions.
Wood CD; Graybiel A
Aerosp Med; 1968 Dec; 39(12):1341-4. PubMed ID: 4881887
[No Abstract] [Full Text] [Related]
4. A comparison of effectiveness of some antimotion sickness drugs using recommended and larger than recommended doses as tested in the slow rotation room. NSAM-945.
Wood CD; Graybiel A; Kennedy RS
Res Rep U S Nav Sch Aviat Med; 1965 Jul; ():1-9. PubMed ID: 5322559
[No Abstract] [Full Text] [Related]
5. Mechanisms of antimotion sickness drugs.
Wood CD; Manno JE; Wood MJ; Manno BR; Redetzki HM
Aviat Space Environ Med; 1987 Sep; 58(9 Pt 2):A262-5. PubMed ID: 3675502
[TBL] [Abstract][Full Text] [Related]
6. The effect of antimotion sickness drugs on habituation to motion.
Wood CD; Manno JE; Manno BR; Odenheimer RC; Bairnsfather LE
Aviat Space Environ Med; 1986 Jun; 57(6):539-42. PubMed ID: 3718377
[TBL] [Abstract][Full Text] [Related]
7. Transdermal scopolamine, oral meclizine, and placebo in motion sickness.
Dahl E; Offer-Ohlsen D; Lillevold PE; Sandvik L
Clin Pharmacol Ther; 1984 Jul; 36(1):116-20. PubMed ID: 6734040
[TBL] [Abstract][Full Text] [Related]
8. Theory of antimotion sickness drug mechanisms.
Wood CD; Graybiel A
Aerosp Med; 1972 Mar; 43(3):249-52. PubMed ID: 4402925
[No Abstract] [Full Text] [Related]
9. Human assay of antimotion sickness drugs.
Graybiel A; Wood CD; Knepton J; Hoche JP; Perkins GF
Aviat Space Environ Med; 1975 Sep; 46(9):1107-18. PubMed ID: 1100039
[TBL] [Abstract][Full Text] [Related]
10. Side effects of antimotion sickness drugs.
Wood CD; Manno JE; Manno BR; Redetzki HM; Wood M; Vekovius WA
Aviat Space Environ Med; 1984 Feb; 55(2):113-6. PubMed ID: 6696702
[TBL] [Abstract][Full Text] [Related]
11. [The treatment of sea-sickness: thiethylperazine in prophylaxis and therapy].
Rubensohn G
Lakartidningen; 1970 Feb; 67(6):619-24. PubMed ID: 5421482
[No Abstract] [Full Text] [Related]
12. Side-effects of 1-hyoscine and cyclizine studied by objective tests.
Brand JJ; Colquhoun WP; Perry WL
Aerosp Med; 1968 Sep; 39(9):999-1002. PubMed ID: 4876723
[No Abstract] [Full Text] [Related]
13. Motion-sickness medications for aircrew: impact on psychomotor performance.
Paul MA; MacLellan M; Gray G
Aviat Space Environ Med; 2005 Jun; 76(6):560-5. PubMed ID: 15945400
[TBL] [Abstract][Full Text] [Related]
14. Effectivity of antimotion sickness drugs during artificial gravity simulations.
Green JA
Aerosp Med; 1973 Nov; 44(11):1255-60. PubMed ID: 4586812
[No Abstract] [Full Text] [Related]
15. Comparative investigation between thiethylperazine and meclizine in vertigo of different genesis.
Jungert S
Acta Otorhinolaryngol Belg; 1978; 32(3):264-72. PubMed ID: 360766
[TBL] [Abstract][Full Text] [Related]
16. Transdermal scopolamine in the prevention of motion sickness: evaluation of the time course of efficacy.
Homick JL; Kohl RL; Reschke MF; Degioanni J; Cintron-Trevino NM
Aviat Space Environ Med; 1983 Nov; 54(11):994-1000. PubMed ID: 6651736
[TBL] [Abstract][Full Text] [Related]
17. Effects of some antimotion sickness drugs and secobarbital on postural equilibrium functions at sea level and at 12,000 feet (simulated).
Fregly AR; Smith MJ; Wood CD; Cramer DB
Aerosp Med; 1973 Feb; 44(2):140-5. PubMed ID: 4687828
[No Abstract] [Full Text] [Related]
18. Evaluation of a new antinauseant drug for the prevention of motion sickness.
Graybiel A; Knepton J
Aviat Space Environ Med; 1977 Sep; 48(9):867-71. PubMed ID: 334151
[No Abstract] [Full Text] [Related]
19. Effects of drug countermeasures for space motion sickness on working memory in humans.
Paule MG; Chelonis JJ; Blake DJ; Dornhoffer JL
Neurotoxicol Teratol; 2004; 26(6):825-37. PubMed ID: 15451046
[TBL] [Abstract][Full Text] [Related]
20. EVALUATION OF SOME ANTIMOTION SICKNESS DRUGS ON THE SLOW ROTATION ROOM (NO. 1). NSAM-922.
WOOD CD; GRAYBIEL A; MCDONOUGH RG; KENNEDY RS
Res Rep U S Nav Sch Aviat Med; 1965 Mar; 15():1-11. PubMed ID: 14313053
[No Abstract] [Full Text] [Related]
[Next] [New Search]
